EifoDefi

Company Overview

Snapshot

Founded in January 2016 by Ariel Hasidim, EifoDefi operates with 1–10 employees. The company has secured funding across one round from Cactus Capital. In May 2020, EifoDefi received funding from Cactus Capital, a student-run venture capital firm.

Business overview

EifoDefi is a Health Tech & Life Sciences company focused on digital accessibility solutions within the healthcare sector. The company develops a social defibrillator mapping app designed to collaboratively map automated external defibrillators (AEDs) in Israel. This mobile application aims to make public AEDs accessible to everyone, serving patients and the broader community by providing real-time, location-based information on critical care devices.

Strategic signal

A February 2022 article highlighted EifoDefi's mission to save lives by mapping defibrillators, emphasizing the critical need for accessible AED information. This signals the company's ongoing commitment to public health and its potential for broader impact in emergency medical response systems, demonstrating the value of its crowdsourced mapping technology.

Company Intelligence Q&A

What is EifoDefi's primary offering?

EifoDefi provides a social defibrillator mapping app that enables collaborative mapping of automated external defibrillators (AEDs) in Israel, making them accessible to the public.

When was EifoDefi founded?

EifoDefi was founded in January 2016 by Ariel Hasidim.

Which investor participated in EifoDefi's funding round?

In May 2020, EifoDefi received funding from Cactus Capital, a student-run venture capital firm.

What is the strategic importance of EifoDefi's app?

The app's strategic importance lies in its ability to save lives by socially mapping public AEDs and making their locations readily available, as highlighted in a February 2022 report.

Where is EifoDefi headquartered?

EifoDefi is based in Be'er Sheva, Israel.